As the season for respiratory syncytial virus (RSV) wages on, several states have reported alarming rates of the virus. These reports call into question the consequence of restricted access to preventative RSV treatment. And it leaves parents of preemies with few options for protecting their babies in communities rife with the deadly virus.
Read more: Institute for Patient Access, March 3, 2015